As healthcare professionals, it is crucial to understand the intricacies of Parkinson's disease, a neurodegenerative disorder impacting millions worldwide. This article aims to provide a comprehensive overview of the condition, its pathophysiology, diagnosis, and management.
Parkinson's disease is characterized by the progressive loss of dopaminergic neurons in the substantia nigra, leading to the classic motor symptoms of tremor, rigidity, and bradykinesia. Non-motor symptoms such as cognitive impairment and mood disorders often precede motor symptoms, reflecting the multisystemic nature of the disease.
Diagnosis is primarily clinical, based on the presence of cardinal motor symptoms and supported by response to dopaminergic therapy. Neuroimaging techniques such as DaTSCAN can provide supportive evidence, but are not routinely required. Early diagnosis is challenging due to the non-specific nature of initial symptoms.
Management is symptomatic, aiming to improve quality of life. Pharmacotherapy with levodopa remains the mainstay of treatment. Dopamine agonists, MAO-B inhibitors and deep brain stimulation are other therapeutic options. Non-pharmacological interventions such as physiotherapy and occupational therapy play a significant role in managing disability.
Research is underway to develop disease-modifying therapies. Novel approaches such as gene therapy and stem cell transplantation are being explored. Understanding the genetic and environmental risk factors can pave the way for preventive strategies.
Parkinson's disease is a complex, multisystem disorder with significant impact on patients' lives. As healthcare professionals, a comprehensive knowledge of its pathophysiology, diagnosis, and management is essential. With ongoing research, we can hope for more effective therapies in the future.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation